Status:
COMPLETED
Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal
Lead Sponsor:
Wonkwang University Hospital
Conditions:
Neuromuscular Blockade Reversal Agent
Perioperative Complications
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
Study Objective: This study aims to evaluate the incidence, severity, and risk factors of sugammadex-induced mouth clenching during neuromuscular blockade (NMB) reversal in adult surgical patients. ...
Detailed Description
This prospective, randomized, double-blind clinical trial aims to investigate the incidence, risk factors, and clinical implications of sugammadex-induced clenching during neuromuscular blockade rever...
Eligibility Criteria
Inclusion
- Eligible participants are adults aged 19-70 years, American Society of Anesthesiologists (ASA) physical status I-II, undergoing elective surgery under general anesthesia with rocuronium.
Exclusion
- Exclusion criteria include neuromuscular disorders, renal impairment (creatinine clearance \< 30 mL/min), history of clenching or dental disease, allergy to study drugs, or emergency surgery.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 14 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06962007
Start Date
May 1 2025
End Date
July 14 2025
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wonkwang University hospital
Iksan, Jeonbuk-do, South Korea, 54538